Podcasts about Clinical

Clinical skills can take years to sharpen. But without trust, connection, and communication, you might never get the chance to use them.In this episode, Matt Glassoff throws a curveball at traditional PT training with a powerful take: if you can't connect with people, your skills don't matter. He breaks down what real patient rapport looks like, how to lead with empathy, and why this message is more important now than ever.???? Topics Covered:Why patients care more about you than your techniquesHow to build trust quickly and authenticallyMistakes Matt made early on — and what he learnedActionable ways to develop human connection in healthcare

Are you wondering why your clinically sound medical device still isn't being adopted—even after pilots, approvals, and glowing data?If you're a clinician founder ready to take your MedTech prototype to market, this episode breaks down the overlooked reason most devices fail to gain traction. It's not the product—it's your go-to-market execution. Learn how behavior change, system fit, and implementation science play a bigger role than your evidence ever will.Discover the #1 mistake clinical founders make after running pilotsLearn how to identify all the “whos” involved in adoption—and why missing one can ruin your rolloutUnderstand how to turn barriers into behavior-changing strategies that scale across bordersPress play to learn the proven system for moving your MedTech device from “great pilot” to international success—without wasting cash or time.Message me via DM on LinkedinBook a 30 min discovery call for the Healthcare Export Accelerator ProgrammeThis podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss screwworm, how the shingles vaccination slows biological aging (for all of you who want to reset 'the clock' and live forever…..you know who you are Musk, Bezos) and getting one dose of the HPV vaccine, then Dr. Griffin then deep dives into recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how losing our elimination status is the cost of doing business (going for broke is never a good business model !) where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, the effectiveness of this season's influenza vaccine, where to go for answers to your long COVID questions and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode New World Screwworm: Outbreak Moves into Northern Mexico……with an official tag "This is an official CDC Health Advisory" (CDC: Health Alert Network) Association between shingles vaccination andslower biological aging: Evidence from a U.S. population-based cohort study (The Journals of Gerontology series A) Noninferiority of One HPV Vaccine Dose to Two Doses (NEJM) Herd effect of human papillomavirus vaccination on incidence of high-grade cervical lesions: (LANCET: Public Health) Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks (USDA: Animal and Plant Health Inspection Service) Detections of Highly Pathogenic Avian Influenza in Wild Birds (USDA: Animal and Plant Health Inspection Service) Delaware, Georgia see major commercial avian flu outbreaks (CIDRAP) Wastewater for measles (WasterWater Scan) Notes from the Field: Wastewater Surveillance for Measles Virus During a Measles Outbreak — Colorado, August 2025 (CDC: MMWR) Notes from the Field: Retrospective Analysis of Wild-Type Measles Virus in Wastewater During a Measles Outbreak — Oregon, March 24–September 22, 2024 (CDC: MMWR) Measles cases and outbreaks (CDC Rubeola) Measles vaccine recommendations from NYP (jpg) Tracking Measles Cases in the U.S. (Johns Hopkins) Utah measles total rises to 216; CDC deputy director says losing elimination status'cost of doing business' (CIDRAP) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Assessing MMR vaccination coverage gaps in US children with digital participatory surveillance (Nature Health) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Effectiveness of influenza vaccination to prevent severe disease: a systematic review and meta-analysis of test-negative design studies (CMI: Clinical Microbiology and Infection) Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026 (Eurosurveillance) Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025 (Eurosurviellance) Current flu vaccine provides moderate protection against severe disease, interim analyses suggest (CIDRAP) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virusnfection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1290 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Jonathan Pearce joins John Murray & Ian Dennis to talk football, travel & language. John is back from Bodø, Jonathan tells tales of changing football on the radio, his thoughts on the Cantona kung-fu kick commentary & Robot Wars reflections. Plus which commentary phrase will JP add to our Great Glossary? Suggestions welcome on WhatsApp voicenotes to 08000 289 369 & emails to TCV@bbc.co.uk00:25 John back from Bodø, 04:00 5 Live commentaries this weekend, 10:55 Does Jonathan like the new Champions League format? 13:15 How Jonathan changed football on the radio, 24:35 Jonathan's best gaffes, 32:25 Cantona's kung-fu kick, 39:05 Robot Wars reflections, 44:40 Great Glossary of Football Commentary, 54:05 Bonus Bobby Moore story.5 Live / BBC Sounds commentaries: Sat 1500 Burnley v Tottenham, Sat 1500 Man City v Wolves, Sat 1730 Bournemouth v Liverpool. Sun 1400 Newcastle v Aston Villa, Sun 1400 Crystal Palace v Chelsea on Sports Extra, Sun 1400 Brentford v Nott'm Forest on Sports Extra 2, Sun 1630 Arsenal v Man Utd, Wed 2000 PSG v Newcastle, Wed 2000 Man City v Galatasaray on Sports Extra, Wed 2000 Napoli v Chelsea on Sports Extra 2.Great Glossary of Football Commentary: DIVISION ONE Back to square one, Bosman, Cruyff Turn, Cultured/educated left foot, Dead-ball specialist, Draught excluder, Elastico/flip-flap Fox in the box, Giving the goalkeeper the eyes, Grub hunter, Head tennis, Hibs it, In a good moment, In behind, Magic of the FA Cup, The Maradona, Off their line, Olimpico, Onion bag, Panenka, Park the bus, Perfect hat-trick, Rabona, Roy of the Rovers stuff, Schmeichel-style, Scorpion kick, Spursy, Tiki-taka, Trivela, Where the kookaburra sleeps, Where the owl sleeps, Where the spiders sleep. DIVISION TWO Back on the grass, Ball stays hit, Beaten all ends up, Blaze over the bar, Business end, Came down with snow on it, Catching practice, Camped in the opposition half, Cauldron atmosphere Coat is on a shoogly peg, Come back to haunt them, Corridor of uncertainty, Couldn't sort their feet out, Easy tap-in, Daisy-cutter, First cab off the rank, Giant-killing, Good leave, Half-turn, Has that in his locker, High wide and not very handsome, Hospital pass, Howler, In the dugout, In their pocket, Johnny on the spot, Leading the line, Nice headache to have, Nutmeg, On their bike, One for the cameras, One for the purists, Played us off the park, Points to the spot, Prawn sandwich brigade, Purple patch, Put their laces through it, Reaches for their pocket, Rolls Royce, Root and branch review, Row Z, Screamer, Seats on the plane, Show across the bows, Slide-rule pass, Steal a march, Straight in the bread basket, Stramash, Taking one for the team, Telegraphed that pass, Tired legs, That's great… (football), Thunderous strike, Turns on a sixpence, Walk it in, We've got a cup tie on our hands. UNSORTED 2-0 is a dangerous score, After you Claude, All-Premier League affair, Aplomb, Bag/box of tricks, Brace, Brandished, Bread and butter, Breaking the deadlock, Bundled over the line, Champions elect / champions apparent, Clinical finish, Commentator's curse, Coupon buster, Denied by the woodwork, Draught excluder, Elimination line, Fellow countryman, Foot race, Formerly of this parish, Free hit, Goalkeepers' Union, Goalmouth scramble, Good touch for a big man, Honeymoon Period, In and around, In the shop window, Keeping ball under their spell, Keystone Cops defending, Languishing, Loitering with intent, Marching orders, Nestle in the bottom corner, Numbered derbies, Opposite number, PK for penalty-kick, Postage stamp, Put it in the mixer, Rasping shot, Red wine not white wine, Relegation six-pointer, Rooted at the bottom, Route One, Sending the goalkeeper the wrong way, Shooting boots, Sleeping giants, Slide rule pass, Small matter of, Spiders web, Stayed hit, Steepling, Stinging the palms, Stonewall penalty, Straight off the training ground, Taking one for the team, Team that likes to play football, Throw their cap on it, Thruppenny bit head / 50p head, Towering header, Two good feet, Turning into a basketball match, Turning into a cricket score, Usher/Shepherd the ball out of play, Walking a disciplinary tightrope, Wand of a left foot, Wrap foot around it, Your De Bruynes, your Gundogans etc.

Therapy isn't confined to an office. Discover how remote sessions are creating deeper breakthroughs and transforming mental health recovery from the comfort of home. Clinical psychologist Lexi Palomo reveals the nuanced frameworks and the power of existential, client-led therapy that are changing lives through a screen. Dive into a conversation that bridges psychology and the legal system, and learn how true curiosity unlocks lasting healing. This is more than a session; it's a new pathway to understanding the mind.

Attention Dental Hygiene Students - This episode breaks down the neuroanatomy of pain control in a way that helps dental hygiene students understand why local anesthesia works, how nerves transmit pain, and what clinicians must consider when applying this knowledge chairside. We connect foundational neuroscience to everyday clinical decision‑making so students can move from memorization to confident practice.In this episode, I want to help you build the confidence you need to rely on your foundational knowledge of neuroanatomy. Additional resources: Leave me a message or send a question I can share on the Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Time Management Prioritization Quiz - Find out how you rate ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Study Sheets: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://thehappyflosserrdh.etsy.com/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Specialized Course: How to be successful in Dental Hygiene School⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://billie-lunt-s-school.teachable.com/p/how-to-be-successful-in-dental-hygiene-school⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Other Podcasts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠blog.feedspot.com/dental_hygiene_podcasts/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Email Me: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HappyflosserRDH@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Leave me a message or ask a question I can share on the Podcast ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Check out my free scorecard for students - you can rank yourself on how you are doing to take action on the steps toward being a successful college student. Study Sheets: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://thehappyflosserrdh.etsy.com/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Specialized Course: How to be successful in Dental Hygiene School⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://billie-lunt-s-school.teachable.com/p/how-to-be-successful-in-dental-hygiene-school⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Lichun marks the release of winter's stagnation and the first stirring of spring Yang. Drawing from classical texts and clinical experience, Yvonne Lau explores how seasonal transition influences Liver Qi and emotional regulation. You can access the written article here: https://www.mayway.com/blogs/articles/lichun-beginning-of-spring-clinical-reflections-on-seasonal-transitionSee our Monthly Practitioner Discounts https://www.mayway.com/monthly-specialsSign up for the Mayway Newsletterhttps://www.mayway.com/newsletter-signupFollow ushttps://www.facebook.com/MaywayHerbs/https://www.instagram.com/maywayherbs/

Dr. Chris Goss (Medicine, Pediatrics; Associate Dean for Clinical Research) discusses ways faculty can partner with industry to fund clinical research, serving their patients with cutting-edge science. Dr. Goss recommends working with your department and the UW Clinical Trials Office who can help with the entire study process including conversations with industry partners, IRB questions, and site-specific resources. He walks through the timeline and responsibilities involved with being a principal investigator in a clinical trial and provides tips for how to be successful amidst common bottlenecks and challenges. Clinical research at UW has grown significantly and may be an excellent pathway for faculty looking to diversify their research funding.Learn about the UW Clinical Trials Office here.Music by Kevin MacLeod (https://incompetech.com/)

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Shelby Williams.

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Shelby Williams.

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Shelby Williams.

Patrick McKenzie (patio11) is joined by Ruxandra Teslo to discuss why drug development keeps getting more expensive despite revolutionary new treatment modalities from GLP-1 agonists to gene therapies. They discuss Eroom's Law (Moore's Law in reverse) and Ruxandra's Common Technical Document Project, which aims to build the "Stack Overflow of clinical development" by making regulatory submissions publicly accessible. This will fill a present hole in the education of researchers, lower barriers for small biotechs, and accelerate drug discovery.–Full transcript available here: https://www.complexsystemspodcast.com/ruxandra-teslo/ –Sponsor: FramerBuilding and maintaining marketing websites shouldn't slow down your engineers. Framer gives design and marketing teams an all-in-one platform to ship landing pages, microsites, or full site redesigns instantly—without engineering bottlenecks. Get 30% off Framer Pro at framer.com/complexsystems.–Links:Eroom's Law (original paper): https://www.nature.com/articles/nrd3681Ruxandra's writing: https://www.writingruxandrabio.com/ Ross Rheingans-Yoo on drug development: https://open.spotify.com/episode/4GiO0KYqxJNCIdltCyhN6m?si=2znQniZ3RXKuX8keNcwWtw Ben Reinhardt on science and development: https://open.spotify.com/episode/0GHegWgLSubYxvATmbWhQu?si=pVCJVITYTqaq65BiST2d0Q–Timestamps:(00:00) Intro(00:56) Challenges in biopharma productivity(03:12) Understanding clinical development(04:59) The role of basic science in drug development(07:39) Clinical development process explained(09:25) Issues in clinical trials and development(19:33) The role of information in clinical trials(20:30) Sponsor: Framer(21:42) The role of information in clinical trials (continued)(32:55) Proposed solutions for clinical development(40:31) Consultant opinions and regulatory documents(41:28) Streamlining the regulatory process(43:06) Understanding FDA interactions(45:35) Building a public library of regulatory documents(48:18) Encouraging novel approaches in biotech(50:06) Addressing risk aversion in the industry(51:52) Analyzing FDA consistency and reviewer heterogeneity(01:02:15) The importance of courage in professional growth(01:06:39) Supporting young professionals and catalyzing change(01:16:14) Wrap

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss 2026 trends. Together, they explore:  JP Morgan Healthcare Conference (00:34): Dr. Morice shares his top observations and takeaways after attending this year's conference. Artificial intelligence (06:02): Anticipated benefits and risks of AI developments predicted in 2026.Reimbursement and regulation (13:43): Why reimbursement and regulation continue to be areas of significant interest in clinical diagnostics. Note: Information in this post was accurate at the time of its posting.ResourcesTransforming laboratory medicine through AI: From promise to practice"Answers From the Lab" podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025"Answers From the Lab" podcast: PAMA Update and Accelerating Research and Development With BioPharma Diagnostics

In this episode of the Hands-On, Hands-Off Podcast, Dr. Trenton Rehman sits down with Dr. Shane McClinton to discuss plantar heel pain and the role of physical therapy in both clinical outcomes and healthcare costs.Dr. McClinton walks through a series of studies stemming from his doctoral research, including a randomized clinical trial, a detailed case series, and a three-year cost-effectiveness analysis. Together, they explore how adding physical therapy to usual podiatry care impacts pain, function, quality of life, and long-term costs.Key themes include manual therapy, impairment-based exercise, proximal contributions to heel pain, interdisciplinary collaboration, and why plantar heel pain may deserve the same clinical mindset as low back pain.Key Takeaways (Listener-Facing)Plantar heel pain is a multidimensional condition with local and proximal contributors.Adding physical therapy to usual podiatry care improved outcomes and reduced costs over three years.Manual therapy and exercise were delivered pragmatically and tailored to impairments.Strengthening may be underutilized in plantar heel pain management.Collaboration between physical therapists and podiatrists benefits patients and reduces downstream burden.⏱️ TIMESTAMPED CHAPTERS (YouTube + Podcast)00:00 – Introduction to the episode and guest00:01 – Dr. Shane McClinton's background and research focus00:03 – Why plantar heel pain referrals to PT are low00:07 – Rationale for studying cost-effectiveness00:10 – Study design overview (RCT + pragmatic approach)00:15 – Description of podiatry-only vs podiatry + PT care00:17 – Inclusion and exclusion criteria00:22 – Case series: why eight different heel pain presentations00:26 – Manual therapy strategies used in the study00:30 – Clinical practice guidelines and decision-making00:32 – Pain mechanisms, education, and chronicity00:35 – Proximal vs local treatment decisions00:38 – Three-year cost-effectiveness results explained00:44 – Implications for referrals and collaboration00:48 – Final take-home message from Dr. McClinton

In this podcast we discuss all the highlights on Day 5 at the Australian Open 2026. The older legends on the men's side continued their good runs with Djokovic, Wawrinka and Cilic and winning in impressive fashion. Sinner made light work of Duckworth 3-0. Hurkacz was defeated comfortably by Ethan Quinn. Alot of straight sets wins on the women's side with Anisimova, Rybakina, Pegula & Swiatek all winning 2-0. ❤️ SUBSCRIBE TO GTL: https://bit.ly/35JyOhz ▶️ JOIN YOUTUBE MEMBERSHIP: https://bit.ly/3Fk9rSr

Send us a textIn senior leadership, how you handle workplace aggression can make or break your executive presence. In this unfiltered episode, Kele Belton exposes the “Peace-Keeper Tax” high-achieving women leaders pay when they choose comfort over authority—and shows you how to respond with calm, visible power instead. You'll learn the P.O.I.S.E. Method so you can stop over-explaining, hold your ground in high‑stakes moments, and reclaim your leadership authority without raising your voice.What This Episode Is AboutSomeone blindsides you in a high-stakes meeting, and your instinct is to jump in, smooth it over, and keep the peace. In this unfiltered masterclass, Kele breaks down how that “helpful” instinct quietly drains your authority, trains people to test your boundaries, and keeps you essential but invisible in senior leadership. You'll discover a practical framework to respond to workplace aggression with poise, stillness, and data-driven authority instead of people-pleasing.What You'll LearnThe Peace-Keeper Tax: Why your urge to de‑escalate and keep everyone comfortable can quietly kill your executive presence and long-term influence.The P.O.I.S.E. Method: A 5-step framework to neutralize workplace aggression, anchor yourself somatically, and stay unmovable when challenged.Stillness as status: How your pacing, posture, and silence signal power—or lack of it—to everyone in the room.Clinical engagement: Specific phrase patterns you can use to redirect a challenge back to the data and reset the power dynamic on your terms.Sarah's story: How one Director stopped a peer's undermining behavior in meetings and earned next-level respect without becoming aggressive or defensive.Who This Is ForSenior leaders and directors who are done being essential but invisible in the rooms where decisions are made.High-achieving women who find themselves managing everyone else's emotions while quietly bleeding authority at work.Ambitious women in middle or senior management who want to strengthen their executive presence and handle public pushback without shrinking, spiraling, or over-explaining.Key Timestamps[00:00] The moment you're blindsided in a high‑stakes meeting.[02:00] Defining the “Peace-Keeper Tax” and its hidden career costs.[07:30] The P.O.I.S.E. Method: Your framework for high‑stakes presence.[11:00] Why stillness is the ultimate status move in senior leadership.[22:00] Monday Momentum announcement and how to stay supported.Mentioned In This EpisodeBook a complimentary Leadership Strategy Call – Get your strategic roadmap to step into senior leadership with more authority and less emotional labor. CLICK HEREMonday Momentum shorty episodes – Starting February 2nd: 5-minute unfiltered leadership strategies every Monday, plus deep-dive episodes every Thursday.Ignite Your Leadership Power Accelerator – For women in middle management ready to step into higher levels of authority, visibility, and compensation. JOIN THE WAITLIST HEREAbout Your Host:Kele Belton is a communication and leadership coach and speaker who specializes in helping women leaders develop confidence and impact through strategic communication and practical leadership frameworks.Connect with Kele for more leadership insights:LinkedIn: https://www.linkedin.com/in/kele-ruth-belton/Instagram: https://www.instagram.com/thetailoreda

Saffron supports both mood and sexual function, addressing a common problem where depression treatments often blunt intimacy Clinical trials show a daily 30-milligram dose of saffron reduces depression symptoms at a level similar to common antidepressants used for mild to moderate depression Unlike many psychiatric drugs, saffron improves erectile function, arousal, lubrication, and sexual satisfaction instead of worsening them Saffron works best when underlying stressors such as inflammation, poor cellular energy production, and gut imbalance are addressed at the same time Consistent daily use for six to eight weeks, combined with stable sleep, movement, sunlight, and a low-seed oil diet, produces the most reliable results

Most herbalists begin with books, teachers, and tradition, but genuine clinical mastery comes from organizing what you know into something you can actually use. In this episode, we will look at why the clinical herbal monograph is the most powerful tool for studying medicinal plants and how to build one that supports real-world practice rather than just theory.   Here's what you'll learn: What defines a clinical herbal monograph The essential elements every useful monograph should include How to think in terms of patterns, rather than "good for" lists Which information is helpful — and what only creates clutter Why writing your own monographs helps you to learn herbs deeply Join The Herbal Monograph Map FREE Workshop Series: https://www.evolutionaryherbalism.com/the-herbal-monograph-map/?utm_medium=social&utm_source=instagram.com&utm_campaign=mmm+optin ———————————— CONNECT WITH SAJAH AND WHITNEY ———————————— To get free in depth mini-courses and videos, visit our blog at:  http://www.evolutionaryherbalism.com   Get daily inspiration and plant wisdom on our Facebook and Instagram channels: http://www.facebook.com/EvolutionaryHerbalism https://www.instagram.com/evolutionary_herbalism/   Be sure to subscribe to our YouTube Channel: https://www.youtube.com/channel/UCyP63opAmcpIAQg1M9ShNSQ   Get a free 5-week course when you buy a copy of the book, Evolutionary Herbalism: https://www.evolutionaryherbalism.com/evolutionary-herbalism-book/   Shop our herbal products:  https://naturasophiaspagyrics.com/   ———————————— ABOUT THE PLANT PATH ———————————— The Plant Path is a window into the world of herbal medicine. With perspectives gleaned from traditional Western herbalism, Ayurveda, Chinese Medicine, Alchemy, Medical Astrology, and traditional cultures from around the world, The Plant Path provides unique insights, skills and strategies for the practice of true holistic herbalism. From clinical to spiritual perspectives, we don't just focus on what herbs are "good for," but rather who they are as intelligent beings, and how we can work with them to heal us physically and consciously evolve.   ———————————— ABOUT SAJAH ———————————— Sajah Popham is the author of Evolutionary Herbalism and the founder of the School of Evolutionary Herbalism, where he trains herbalists in a holistic system of plant medicine that encompasses clinical Western herbalism, medical astrology, Ayurveda, and spagyric alchemy. His mission is to develop a comprehensive approach that balances the science and spirituality of plant medicine, focusing on using plants to heal and rejuvenate the body, clarify the mind, open the heart, and support the development of the soul. This is only achieved through understanding and working with the chemical, energetic, and spiritual properties of the plants. His teachings embody a heartfelt respect, honor and reverence for the vast intelligence of plants in a way that empowers us to look deeper into the nature of our medicines and ourselves. He lives on a homestead in the foothills of Mt. Baker Washington with his wife Whitney where he teaches, consults clients, and prepares spagyric herbal medicines.    ———————————— WANT TO FEATURE US ON YOUR PODCAST? ———————————— If you'd like to interview Sajah or Whitney to be on your podcast, click here to fill out an interview request form.

Did you know that nearly 50% of women experience hair changes during menopause? In this expert-led conversation, we uncover the truth behind menopausal hair thinning, shedding, and texture changes with Dr. Isabelle Raymond, SVP of Clinical and Medical Affairs at Nutrafol. Dr. Raymond is dedicated to advancing women's health, with a particular focus on the biological and lifestyle factors that impact hair health during midlife. We explore the six root causes of hair thinning, the critical role of nutrition and hormones in hair growth, and why clinically backed research is essential for proven hair wellness solutions. Show Notes/Links: www.hotflashescooltopics.com Nutrafol: Link WE GREATLY APPRECIATE 5 STARS AND REVIEWS! Find Us Here! Website I [http://hotflashescooltopics.com/] Mail I [hotflashescooltopics@gmail.com] Instagram I [https://www.instagram.com/hotflashesandcooltopics/] Facebook : [www.facebook.com/hotflashescooltopics] YouTube I [https://www.youtube.com/@HotFlashesCoolTopics] Pinterest I [https://www.pinterest.com/hcooltopics/]

At some point in your career as a therapist, the work begins to shift. You may feel a quiet pull to share what you've learned beyond the therapy room but feel unsure what that means or whether you're "qualified" to teach. In this episode, I explore the transition from clinician to educator and why this identity shift can feel both exciting and uncomfortable. I talk about common myths therapists hold about teaching, ethical considerations, visibility, and how stepping into an educator role doesn't require a new certification or a major career change. If you're a mid-career or seasoned clinician curious about teaching, mentoring, or continuing education, this episode is an invitation to notice the pull and explore it with clarity and confidence. Links mentioned:

Pediatric neuropalliative medicine is an emerging area of subspecialty practice that emphasizes the human experience elements of serious neurologic illness. Child neurologists care daily for patients who can benefit from the communication strategies and management practices central to pediatric neuropalliative medicine, whether at the primary or subspecialty level. In this episode, Gordon Smith, MD, FAAN, speaks with Lauren Treat, MD, author of the article "Neuropalliative Medicine in Pediatric Neurology" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Smith is a Continuum® Audio interviewer and a professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Treat is an associate professor in the divisions of child neurology and palliative medicine at the University of Colorado School of Medicine in Aurora, Colorado. Additional Resources Read the article: Neuropalliative Medicine in Pediatric Neurology Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @gordonsmithMD Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Smith: This is Gordon Smith. Today I've got the great pleasure of interviewing my good friend Dr Lauren Treat about her article on neuropalliative medicine in pediatric neurology practice. This article appears in the December 2025 Continuum issue on neuropalliative care. Lauren, welcome to the Continuum podcast, and maybe you can introduce yourself to our listeners. Dr Treat: Such a delight to be here, Gordon. Thank you. I am a pediatric neurologist and palliative medicine doctor at the University of Colorado, Children's Hospital Colorado, and I am practicing in both areas. I do general child neurology, and I also run a pediatric neuropalliative medicine clinic. So, I'm happy to be here to talk about it. Dr Smith: And, truth in advertising, I tried very hard to get Dr Treat to move to VC to work with me. And I haven't given up yet. I'm looking forward to the conversation. And Lauren, I wonder- one, I'm really excited about this issue, by the way. This is the second podcast I've done. And I'd like to ask the same question I asked of David Oliver, who's amazing. What a great article and conversation we had. And that question is, can you define palliative care? I think a lot of people think of it as, like, end-of-life care or things like that. And is the definition a little different in the pediatric space than it is in the adult space? Dr Treat: Such a great place to start, Gordon. I absolutely think that there are nuances that are very important in pediatrics. And we especially acknowledge in pediatrics that there is a very longitudinal component of this. And even moreso, I think, then in adult neuropalliative medicine, in pediatrics, we are seeing people=even prenatally or early in their first hours and days of life, and walking with them on a journey that might last days or weeks, but might last years or decades. And so, there is this sense that we are going to come alongside them and be part of the ups and the downs. So yes, neuropalliative medicine is a kind of medicine that is a very natural partner to where neurology is in its current field. We're doing a lot of exciting things with modifying diseases, diagnosing things early, and we have a very high reliance on the things that we can measure in medicine. And not all things can be measured that are worthwhile about one's quality of life. A family very poignantly told me very recently, making sure someone stays alive is different from making sure they have a life. And that's what neuropalliative medicine is about. Dr Smith: Well, great summary, and I definitely want to follow up on several aspects of that, but there's one point I was really curious about as I've been thinking about this, you know, these are really exciting times and neurology in general and in child neurology in particular. And we've got all of these exciting new therapies. And as you know, I'm a neuromuscular person, so it's hard not to think back on SMA and not be super excited. And so, I wonder about the impact of these positive developments on the practice of neuropalliative care in kids. You know, I'm just thinking, you know, you mentioned it's a journey with ups and downs. And I wonder, the complexity of that must be really interesting. And I bet your job looks different now than it did seven or eight years ago. Dr Treat: That's absolutely true. I will self-reference here one of the figures in the paper. Figure 2 in my section is about those trajectories, about how these journeys can have lots of ups and downs and whether this person had a normal health status to begin with or whether they started out life with a lot of challenges. Those ups and downs inherently involve a lot of uncertainty. And that's where palliative medicine shines. Not because we have the answer---everyone would love for us to have the answer---but because we consider ourselves uncertainty specialists in the way that we have to figure out what do we know, what can we ground ourselves in, and how can we continue to move forward even if we don't have all the answers? That is a particular aspect of neurology that is incredibly challenging for families and clinicians, and it can't stand as a barrier to moving forward and trying to figure out what's best for this child, what's best for this family. What do we know to be true about them as people, and how can we integrate that with all of the quantitative measures that we know and love in neurology? Dr Smith: So, I love the comment about prognostication, and this really ties into positive uncertainty or negative undercertainty in terms of therapeutic development. I wonder if you can talk a little bit about your approach to prognostication, particularly in a highly fluid situation. And are there pearls and pitfalls that our listeners should consider when they're discussing prognosis for children, particularly maybe young children who have severe neurological problems? Dr Treat: It's such a pivotal issue, a central issue, to child neurology practice. Again, because we are often meeting people very, very early on in their journey---earlier than we ever have before, sometimes, because of this opportunity to have a diagnosis, you know, prenatally or genetically or whatever else it is---sometimes we are seeing the very early signs of something as compared to previously where we wouldn't have a diagnosis until something was in its more kind of full-blown state. This idea of having a spectrum and giving people the range of possible outcomes is absolutely still what we need to do. However, we need to add on another skill on top of that in helping people anchor into what feels like the most likely situation and what the milestones are going to be in the near future, about how we're going to walk this journey and what we'll be on the lookout for that will help us branch into those different areas of the map down the road. Dr Smith: So, I wonder if we can go back to the framework you mentioned, two answers ago, I think? You and the article, you know, provide four different types of situations kind of based on temporal progression. I wonder if maybe the best way of approaching is to give an example and how that impacts your thoughts of how you manage a particular situation. Dr Treat: Absolutely. So, this figure in particular is helpful in multiple ways. One is to just give a visual of what these disease trajectories are doing, because we're doing that when and we take a history from a patient. But actually, to put it into an external visual for yourself, for your team, but also perhaps for the family can be really powerful. It helps you contextualize the episode of care in which you're meeting the family right now. And it also helps, sometimes, provide some sense of alignment or point out some discrepancies about how you're viewing that child's health and quality of life as compared to how the family might be viewing it. And so, if you say, you know, it sounds like during those five years before we met, you were up here, and now we find ourselves down here, and we're kind of in the middle of the range of where I've seen this person's health status be. Do I have that right? Families feel really seen when you do that and when you can get it accurately. And it also invites a dialogue between the two parties to be able to say, well, maybe I would adjust this. I think we had good health or good quality of life in this season. But you're right, it's getting harder. It's kind of that "show, don't tell" approach of bringing together all the facts to put together the relative position of where we are now in the context of everything they've been through. Dr Smith: You know, I wonder if you could talk a little bit more about the differences between palliative care and adult patients and in children? Dr Treat: Absolutely. One of the key features in pediatrics is this kind of overriding sense of an out-of-order event in the family's life. Children are not supposed to have illness. Children are not supposed to have disability. Children are not supposed to die before their parents. And that layer of tragedy is incredibly heavy and pervasive. It's not every encounter that you have in child neurology, but it does kind of permeate some of the conversations that neurologists have with their patients, especially patients who have serious neurological disease. So that could be things like epileptic encephalopathies, birth injuries, other traumatic brain injuries down the line. In the paper, I'd go through many different categories of the types of conditions that are eligible for pediatric neuropalliative medicine, that kind of support. When we think about that layer of tragedy in the relation to where we're meeting these families, they deserve extra support, not just to think about the medicines and the treatments, but also, what can we hope for? How can we give this child the best possible life in whatever circumstance that they're in? How can we show up in whatever medical decision-making circumstances present themselves to us and feel like we've done right by this child? It's a complex task, and pediatric neural palliative medicine is evolving to be able to be in those spaces with families in a very meaningful way. Dr Smith: So, of course, one of the differences is the, you know, very important role of parents in the situation, right? Obviously, parents are involved in adult palliative care issues and family is very important. But I wonder if you can talk about specific considerations given the parent-child relationship? Dr Treat: So, pediatric neuropalliative medicine really helps facilitate discussions not just about, again, those things that we have data on, but also about what is meaningful and foundational for those families. What's possible at home, what's possible in the community. In pediatrics, parents are making decisions on behalf of their child, often as a dyad, and I don't think this gets enough attention. We know from adult literature that making decisions on behalf of someone else is different from making decisions on behalf of oneself. We call this proxy decision-making. And proxies are more likely to be conservative on behalf of someone else than they are on behalf of themselves, and they're also more likely to overestimate the tolerability of a medical intervention. So, they might say, I wouldn't want this, or, I wouldn't accept this risk on behalf of myself, or, I don't think I'd want to have to persevere through something, but on behalf of this other person, I think they can do it or I will help them through it or something else like this, or, I can't accept the risk on behalf of them. So that's not good or bad. That's just different about making a decision on behalf of oneself as compared to making a decision on behalf of someone else. When there's two people trying to be proxies on behalf of a third person, on behalf of a child, that's a really, really complex task, and it deserves support. And so, pediatric neural palliative medicine can function, then, as this neutral space, as this kind of almost coaching opportunity alongside the other medical doctors to give parents an opportunity when their minds are calm---not in the heat of the moment---to talk about how they see their child, how they've shown up themselves, what they've seen go well, what they've struggled with. And how,, then we can feel prepared for future decision making times, future high-stress encounters, about what will be important to ground them in those moments, even though we can't predict fully what those circumstances might be. Dr Smith: It sounds, you know, from talking to you and having read the article, that these sorts of issues evolve over time, right? And you have commented on this already from your very first answer. And you do describe a framework for how parents think---their mental model, I guess---of, you know, a child with a serious illness. And this sounds like appreciation of that's really important in providing care. Maybe you can talk us through that topic? Dr Treat: I refer to this concept of prognostic awareness in all of the conversations that we have with families. So, what I mean by prognostic awareness is the degree of insight that an individual has about what's currently happening with their child and what may happen in the future regarding the disease and/or the complications. And when we meet people early on in their journey, often their prognostic awareness, that sense of insight about what's going on, can be limited because it requires lived experience to build. Oftentimes time is a factor in that, we gain more lived experience over time, but it's not just time that goes into building that. It's often having a child who has a complication. Sometimes it's experiencing a hospitalization. That transfer from a cognitive understanding of what's going on, from a lived experience about what's going on, really amplifies that prognostic awareness, and it changes season by season in terms of what that family is going through and what they're willing to tolerate. Dr Smith: You introduced a new term for me, which is hyper-capableism. Can you talk about that? I found that really interesting and, you know, it reminds me a lot of the epiphanies that we've had about coma and coma prognosis. So, what's hyper-capableism? Dr Treat: Yes. In neurology, we have to be very aware of our views on ableism, on understanding how we prognosticate in relation to what we value about our abilities. And hyper-capableism refers to someone who feels very competent both cognitively and from a motor standpoint and fosters that sense of value around those two aspects to a high degree. I'm referencing that in the article with regard to medicine, because medicine, the rigors of training, the rigors of practice, require that someone has mental and motor fortitude. That neurology practice and medical practice in general can breed this attitude around the value of skills in both of those areas. And we have to be careful in order to give our patients and families the best care, to not overly project our values and our sense of what's good and bad in the world regarding ableism. Impairments can look different in different social contexts. And when the social context doesn't support an impairment, that's where people struggle. That's where people have stigma. And I think there's a lot of work that we can do in society at large to help improve accommodations for impairment so that we have less ableism in society. Dr Smith: Another term that I found really interesting kind of going back to parents is the "good parent identity." Maybe you can talk about that? Dr Treat: Good parent identity, good parent narrative, is something that is inherent to the journey when you're trying to take care of and make decisions on behalf of a child. And whether you're in a medical context or outside of a medical context, all parents have this either explicit or implicit sense of themselves about what it means to do right by their child. This comes up very poignantly in complex medical conditions because there are so many narratives about what parents ought to do on behalf of their child, and some of those roles can be in tension with one another. It's a whole lot of verbs that often fall under that identity. It's about being able to love and support and take good care of and make good decisions on behalf of someone. But it's also about protecting them from harm and treating their pain and being able to respond to them and know their cues and know these details about them. And you can't, sometimes, do multiple of those things at once. You can't give them as much safety and health as possible and also protect them from pain and suffering when they have a serious illness, when they need care in the hospital that might require a treatment that might be invasive or burdensome to them. And so, trying to be a good parent in the face of not being able to fulfill all those different verbs or ideas about what a good parent might do is a big task. And it can help to make it an explicit part of the conversation about what that family feels like their good parent roles might be in a particular situation. Dr Smith: I want to shift a little bit, Lauren, that's a really great answer. And just, you know, listening to you, your language and your tongue is incredibly positive, which is exciting. But, you know, you have talked about up and downs, and I wanted you to comment on a quote. I actually wrote it down, I'm going to read it to you, because you mentioned this early on in your article: "the heavy emotional and psychological impacts of bearing witness to suffering as a child neurologist." I think all of us, no matter how excited we are about all the therapeutic development, see patients who are suffering. And it's hard when it's a child and you're seeing a family. I wonder if you could talk a little bit about that comment and how you balance that. You're clearly- you're energized in your career, but you do have to bear witness to suffering. Dr Treat: You're right. Child neurologists do incredible work, it's an incredible, exciting field, and there are a lot of challenges that we see people face. And we see it impacts their lives in really intense ways over the course of time. We bear witness to marriages that fall apart. We bear witness to families that lose jobs or have to transition big pieces of their identity in order to care for their children. And that impacts us. And we hold the collective weight of the things that we are trying to improve but sometimes feel less efficacious than we hoped that we could around some of these aspects of people's lives. And so, pediatric neuropalliative medicine is also about supporting colleagues and being able to talk to colleagues about how the care of the patients and the really real effort that we exert on their behalf and the caring that we have in our hearts for them, how that matters. Even if the outcome doesn't change, it's something that matters for our work and for our connections with these families. It's really important. Dr Smith: I wonder, maybe we can end by learning a little bit about your journey? And maybe this is your opportunity to- I know we have students and residents who listen to us, and junior faculty. I think neuropalliative care is obviously an important issue. There's a whole Continuum issue on it---no pun intended---but what was your journey, and maybe what's your pitch? Dr Treat: I'm just going to give a little bit of a snippet from a poem by Andrea Gibson, who's a poet, that I think speaks really clearly to this. They say a difficult life is not less worth living than a gentle one. Joy is simply easier to carry than sorrow. I think that sums these things up really well, that we find a lot of meaning in the work that we do. And it's not that it's easier or harder, it's just that these things all matter. I'm going to speak now, Gordon, to your question about how I got to my journey. When I went into pediatrics and then neuro in my training, I have always loved the brain. It's always been so crucial to what I wanted to do and how I wanted to be in the world. And when I was in my training, I saw that a lot of the really impactful conversations that we were having felt like we left something out. It felt like we couldn't talk about some of the anticipated struggles that we would anticipate on a human level. We could talk about the rate and the volume of the G tube, but we couldn't talk about how this was going to impact a mother's sense of being able to nourish and bond and care for their child because we didn't have answers for those things. And as I went on in my journey, I realized that even if we don't have answers, it's still important for us to acknowledge those things and talk about them and be there for our patients in those conversations. Dr Smith: Well, Lauren, what a great way to end, and what a wonderful conversation, and what a great article. Congratulations and thank you. Dr Treat: Thank you, Gordon. It was a pleasure to be here. Dr Smith: Again today, I've been interviewing Dr Lauren Treat about her really great article on neuropalliative medicine in pediatric neurology practice. This article appears in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this issue and other issues. And thanks again to you, our listeners, for joining us today. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

This week's episode of the MidPoint is a little different. It's brought to us in collaboration with our friends at One Day Tests.I was drawn to working with One Day Tests as a lot of the information I have around my health is based on instinct or long-term changes, but I wanted to see if the nuances of what my blood could tell me would make a difference to my habits.We are fed a lot of information about how we are living longer and what is good for us, and then a lot of information about opposite - our health challenges and lifestyle problems.I sat down with Medical Director Dr Adam Staten and Kate Davies, Clinical lead for Women's Services at One Day Tests to chat about what a lot of this really means and how understanding out biomarkers can give us a confidence to making positive changes. Let us know on Instagram what minor changes you've made that have had a proper impact.For more information visit www.onedaytests.com and for £10 off use code GABBY10. Hosted on Acast. See acast.com/privacy for more information.

Vilte E Barakauskas, Samantha Pawer, Wee-Shian Chan, Benjamin P Jung. Unmet Clinical Needs and Remaining Challenges of Pregnancy Reference Intervals. Clinical Chemistry, Volume 72, Issue 1, January 2026, Pages 47–60. https://doi.org/10.1093/clinchem/hvaf150

Twenty years of restless legs. Two failed attempts. One patient who kept coming back anyway. In this episode, I finally figured out what was missing - and it had nothing to do with magnesium, valerian, or sleep hygiene before bed. This case humbled me. I'd treated her twice before with all the "right" things - minerals, adaptogens, calming herbs, etc., and nothing worked. When she came back a third time, desperate and hardly sleeping, I knew I had to dig deeper. What I found changed how I think about restless leg syndrome entirely. RLS isn't a muscle problem. It's not a simple mineral deficiency. It's a nervous system excitability disorder driven by overlapping dysfunctions: dopamine signaling, brain iron metabolism, inflammation, and liver function. I discovered the smoking gun was a protein called hepcidin which controls iron trafficking in the body. When inflammation is high and the liver is congested, iron gets trapped. The brain starves. Dopamine drops. And the legs can't stop moving. In this episode, I walk you through the research that opened my eyes, the labs that finally made sense, and the Phase One protocol I built from scratch. After just two weeks, she's already seeing improvement - not because I treated her legs, but because I treated the right things in the right order. If you've ever had a case that forced you to start over, this one's for you. Download the 6 Principles of Clinical Thinking Join Clinical Academy

For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes – a fascinating conversation with our beloved Medical Director, Dr. Chris Turnpaugh, where we discuss chronic infections, immune dysregulation, and detox strategies. This interview first aired early last year (2025), and the full interview can be viewed here.   Clinical pearls we extracted from the original interview: Overview of chronic infections and the immune system The role of environmental toxins on the immune system/immune response Addressing toxic burden and supporting detoxification Various therapeutic interventions Lyme disease and Long Covid (and other complex client cases) Foundational immune support    The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/   Connect with Dr. Chris Turnpaugh: Website: TurnpaughHWC.comFacebook: https://www.facebook.com/TurnpaughHWC/ Instagram: TurnpaughHealth    Timestamps:  00:00 TH1 vs. TH2 Immunity Explained 03:32 "Reducing Toxic Burden Strategies" 08:19 "NAC: The Ultimate Supplement" 11:09 "Master Clinical Skills, Transform Lives"   Speaker bio: Dr. Chris Turnpaugh is a practitioner and CEO at Turnpaugh Health, a Functional Medicine wellness center, which he founded in 1999. The center, one of the largest in the country, has grown to over 20 healthcare providers and a team of more than 50 in five locations.  Turnpaugh Health provides in-depth holistic care focusing on functional medicine, investigating the mechanisms of dysfunction in patients. The clinic also provides integrative family medicine, lifestyle medicine, and many complementary wellness services.  Over his twenty years in practice, Dr. Turnpaugh has joined ILADS and is known as a thought leader in Lyme disease and associated co-infections. He also traveled to Lake Como to participate on the PANDAS International board. He has a deep interest and extensive knowledge in pediatric neurological disorders and methods of supporting these children holistically. Dr. Turnpaugh has lectured on a broad variety of health topics, both nationally and internationally.  His application of functional medicine as it relates to the neuro/endocrine/immune systems is a unique clinical approach to non-pharmacological treatments. He is well respected among his peers and patients as a provider and functional medicine instructor. He has treated thousands of patients in his practice and mentored hundreds of practitioners. His true passion is teaching functional medicine to other practitioners and helping patients to optimize their health.   Keywords: functional health practitioners, clinical skills, chronic disease, restoring balance, chronic infections, immune system, TH1, TH2 dominance, autoimmunity, cancer, chemicals, pesticides, endocrine disrupting compounds, toxic burden, gut symptoms, liver, bile flow, digestion, nutrient supplementation, detoxification, sauna therapy, nasal spray, peptide therapy, liposomal glutathione, NAC, vitamin D, immune dysregulation, long Covid, post-treatment Lyme disease, food intolerances, chemical sensitivities, microbiome Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.  

On this Episode our special guest has been in the wellness industry for more than 40 years. She has counseled thousands one-on-one in wellness and nutrition.I have had the pleasure of being educated by her over the years and that special guest is Kim Bright the founder of Brightcore Nutrition. Kim's here to share with us the ins and outs of Collagen with a highlight on one of Brightcore's most popular products, Revive.Collagen makes up the structure of our cells and tissues – thus impacting every area of our health. One of the most well-documented benefits of collagen is its positive impact on skin health. Clinical trials have shown that collagen supplementation can significantly enhance skin elasticity, reduce the appearance of wrinkles, and contribute to a more youthful complexion.Additionally, collagen plays a crucial role in supporting joint and bone health. Research suggests that collagen supplementation may help alleviate joint pain and stiffness, particularly in individuals with conditions like osteoarthritis. Collagen is also a component of tendons and ligaments, making it important for overall joint function.Talking Points:Why do we need Collagen?What happens to Collagen during Aging?Why having 5 forms is imperative.Why is collagen good for bones and joints?How does collagen benefit skin, hair and nails?Buy 2 bottles of Revive, Get 1 bottle Free.Available only by phone call at 888-958-5331.Call in and ask about the “Family and Friends” packages for even more savings.

Send us a textDr. Michael Koren joins Kevin Geddings to explain what "Phase 1" means in the context of clinical research. The doctor talks about how phase 1 is the first time a new investigational treatment is used in a person, but that there is an enormous amount of work that happens before a medication gets to that point. He also discusses the other phases of research, concerns about safety, and why clinical research is so important.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

In this episode of Skin Anarchy, Dr. Ekta Yadav welcomes Carolina Reis Oliveira and Alessandra Zonari, co-founders of OneSkin, for a rigorous, eye-opening conversation that reframes skincare as a true longevity intervention. Part of the Lessons in Longevity series, this episode asks a bold question: what if skin aging isn't cosmetic at all—but cellular, systemic, and deeply biological?OneSkin began not as a brand, but as a lab-based mission. Trained in stem cell biology, tissue engineering, and genomics, Carolina and Alessandra spent years growing real human skin in the lab to test existing products. What they found challenged the industry: many so-called “anti-aging” formulas increased inflammation, cellular stress, and long-term damage. Meanwhile, longevity science was accelerating—yet skin, the body's largest organ, was being left out of the conversation.At the center of the episode is cellular senescence—a state where damaged cells stop dividing and begin secreting inflammatory signals that degrade surrounding tissue. In skin, this process weakens the barrier, disrupts collagen, and accelerates visible aging. Rather than masking symptoms, OneSkin set out to target this root cause. After screening hundreds of compounds, they developed OS-01, a proprietary peptide shown in lab models to significantly reduce senescent cell burden while increasing collagen—without irritation.The conversation also expands beyond the face. OneSkin's decision to focus on body skin revealed something unexpected: improving the skin barrier may reduce systemic inflammation. Clinical data discussed in the episode suggests that healthier skin doesn't just look better—it may influence whole-body aging.This episode is a must-listen for anyone curious about where skincare, biotech, and longevity science truly intersect.Listen to the full episode of Skin Anarchy to hear how OneSkin is redefining skin as a living organ—and why the future of longevity may start at the surface.SHOP ONESKINDon't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

This episode explores a real-world medical incident where a costly error changed lives and provokes tough questions about accountability in medicine. Through candid storytelling and critical commentary, Drs. Tim and May Hindmarsh examine how such mistakes unfold, the role of clinician condition and decision-making, and what it reveals about broader challenges in clinical practice.GET SOCIAL WITH US!

Clinical trial budgeting remains one of the biggest bottlenecks in study startups, driving delays, rework, and frustration across sponsors, CROs, and research sites. In this episode of the Clinical Trial Podcast, recorded live at Research Revolution, a clinical research conference hosted by Florence Healthcare, we take a hard look at why clinical trial budget negotiations continue to break down—and what experienced operators are doing differently. This conversation brings together sponsor, site, and consultant perspectives to unpack the real drivers of delay, including slow escalation pathways, unclear or inconsistent budget justifications, misaligned expectations, and communication gaps between stakeholders. Rather than rehashing theory, this episode focuses on practical, experience-driven insights you can actually apply. In this episode, you'll learn: The most common causes of delays during clinical trial budget negotiations How sites can create clear, defensible budget justifications without triggering endless revision cycles What sponsors look for when approving higher-than-expected line items Best practices for internal rate cards, fee schedules, and budgeting templates How improved communication and transparency can reduce negotiation friction and speed study startup This episode features insights from: Kristen McKenna, Senior Manager and Investigator Contracts Lead at Pfizer Heidi Castle, Director of Business Development at Mercy Research Matt Lowery, CEO and Principal Consultant at The Pathways Group If you're involved in clinical trial budgeting, contracting, or study startup - whether at a sponsor, CRO, or research site - this episode offers practical insights to help you navigate negotiations more effectively and avoid common pitfalls. Listen to the episode to hear how sponsor, site, and consultant leaders approach clinical trial budgeting and study startup.

Dr. Josie Traub-Dargatz, Professor Emeritus of Internal Medicine (retired) from Colorado State University College of Veterinary Medicine and Biomedical Sciences in 2017.   In this episode - learn about: Neonatal Isoerythrolysis (N.I.) A life-threatening condition that is more common in mule foals. Learn how to prevent it.Clinical signs recognized in the first few days of the foal's life and perhaps up to 12 days of age include: a) Weakness and lethargy, b) Decrease in suckling the mare c) Rapid breathing, d) Pale or yellow discoloration of the mucous membranes. e) Red color to the urine f) In severe cases collapse and death can occur. 1 in 10 mule foals is at risk for this disease.How to determine if the foal is at risk for N.I. Learn how N.I. can be prevented.Mule Talk is an Every Cowgirl's Dream production - www.EveryCowgirlsDream.Com www.MuleTalk.Net Meredith Hodges Interviews: www.LuckyThreeRanch.Com/Podcast-Appearances/

Is your medical device vision actually helping you grow - or silently holding you back?If you're a clinician founder with a working prototype but struggling to scale or export your medical device, the problem likely isn't your product — it's your vision. In this episode, Hakeem Adebiyi breaks down why most healthcare innovations stall commercially and how to fix it using a proven, clinician-friendly framework.Here's what you'll learn:Why your current vision might be too generic — and how that's stalling your commercial growthThe DAMP framework: a 4-step system to pressure test your vision for direction, alignment, motivation, and peopleA practical on-the-go exercise to sharpen your vision and guide real business decisions immediately

In his weekly clinical update, Dr. Griffin and Vincent Racaniello are bewildered and dismayed by RFK Jr's announced changes in the routine childhood immunization schedule, though not unpredicted, and highlight the science and evidence which eviscerate these changes, then deep dives into recent statistics on the measles epidemic- in particular in South Carolina, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, estimated societal burden of COVID-19 illness, deaths and hospitalizations, benefit of maternal COVID-19 vaccination, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, neurodevelopmental consequences of in-utero SARS-CoV-2 infection and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode 7 great Danish cheeses you should know (Cheese Professor) Norovirus in on the rise! (WasterWater Scan) Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis (JAMA Open) TUESDAY MEASLES UPDATE: DPH Reports 124 New Measles Cases in Upstate, New Public Exposures, and Upcoming Vaccination Opportunities (South Carolina: Department of Public Health-they have one?) Measles cases soar in South Carolina, top 400 (CIDRAP) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) North Dakota confirms pediatric flu deaths as some states note surge in flu activity (CIDRAP) OPTION 2: XOFLUZA $50 Cash Pay Option (Xofluza) The Best Flu Drug Americans Aren't Taking (The Atlantic) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study (Lancet: Infectious Diseases) Interim Safety of RSVpreF Vaccination During Pregnancy (JAMA) Pfizer's RSV vaccine safe to use during pregnancy, study suggests (CIDRAP) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Evaluating the Effectiveness of 2024–2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort Study (Infectious Diseases and Therapy) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis(Scientific Reports) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Incidence and Severity of Postacute Sequelae of SARS-CoV-2 Infection in the Omicron Era: A Prospective Cohort Study (JID) Reaching out to US house representative Letters read on TWiV 1288 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Send us a textCould a simple blood test help identify chronic pulmonary hypertension when echo access is limited? This week on The Incubator Podcast, Ben and Daphna explore this question and others relevant to daily NICU practice. A Toronto study examines NT-proBNP as a practical diagnostic tool in extremely preterm infants.They also examine a puzzling finding from Italy and Belgium: despite near-universal antibiotic use in neonates with HIE undergoing cooling, actual culture-positive sepsis rates are surprisingly low. What does this mean for our approach to empiric antibiotics?Ben presents Norwegian data showing that serial physical exams cut antibiotic exposure in half for term and late preterm infants—without compromising safety. Daphna follows with research connecting NICU capacity strain to patient outcomes, underscoring why adequate staffing isn't just about comfort, but about survival.The episode concludes with Ben, Daphna, and Eli discussing the recent CDC changes to Hepatitis B birth dose recommendations. With federal guidance now diverging from AAP recommendations, how do we navigate conversations with families? They explore transmission risks parents may overlook and share approaches to shared decision-making when expert opinions conflict. A full week of neonatal medicine research and real-world clinical challenges, all in one episodeSupport the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode of The Scope Forward Show, Praveen Suthrum speaks with Alex Noumidis, Co-founder and CEO of Nerva, a digital therapeutic platform for IBS (Irritable Bowel Syndrome) and other disorders of gut-brain interaction. They discuss the origins of Nerva, the science of psychophysiology, digital health adoption in GI, and the challenges of bringing behavioral therapies into mainstream gastroenterology. The conversation dives deep into the power of gut-directed hypnotherapy, its clinical validation, the bottlenecks in scaling access to GI psychology, and what it takes to build a product that patients actually use. They've seen 300,000 patients and plan to expand to all GI conditions. Recorded between Australia and Mumbai, this global conversation also reflects on the evolving landscape of GI care.*

In this episode, I sit down with Gary Stapleton to unpack the complexity of small intestinal bacterial overgrowth and why it is so often overlooked in clinical practice. We discuss the true prevalence of SIBO, how it contributes to both digestive and systemic symptoms, and why accurate diagnosis is essential for meaningful treatment outcomes. Gary shares his expertise on breath testing as the cornerstone of proper SIBO diagnosis. We break down the differences between glucose, lactulose, and fructose substrates, explain when each should be used, and highlight common testing errors that can lead to confusion or misdiagnosis. This portion of the conversation brings clarity to a topic that is frequently misunderstood. We also explore how SIBO overlaps with other gastrointestinal and systemic conditions and why an individualized approach matters. This episode provides a practical framework for understanding SIBO testing and treatment and is essential listening for anyone looking to move beyond trial and error and toward precision based gut health care.   Key takeaways: SIBO is characterized by an abnormal increase of bacteria in the small intestine, often leading to digestive and systemic health issues. Accurate testing and proper preparation are crucial for a reliable diagnosis of SIBO. The choice of substrate (glucose, lactulose, fructose) plays a critical role in breath testing accuracy. Understanding the symptoms and co-occurring conditions of SIBO can guide effective treatment strategies. Collaboration between laboratories and healthcare practitioners is essential for optimal patient care and treatment outcomes.   More About Gary Stapleton:   Gary Stapleton is the founder and Chief Executive Officer of Aerodiagnostics, LLC, where he focuses on advancing diagnostic accuracy and improving clinical decision making in functional and gastrointestinal health. With decades of leadership experience in healthcare diagnostics and pharmaceuticals, Gary brings a deep understanding of how precision testing can transform patient outcomes. Prior to founding Aerodiagnostics, Gary held senior executive roles across major healthcare organizations, including Chief Operating Officer at Calloway Laboratories, Vice President of Sales and Marketing at Bausch & Lomb, and leadership positions at Caris Life Sciences and Lerner Medical Devices. Earlier in his career, he spent 14 years at AstraZeneca, where he played a key role in the launch and commercialization of multiple blockbuster therapies. A former member of the United States Marine Corps, Gary combines disciplined leadership with a passion for innovation in healthcare. He holds an undergraduate degree from Long Island University and an MBA, and founded Aerodiagnostics. Website Instagram Connect with me! Website Instagram Facebook YouTube

John Murray, Ian Dennis & Ali Bruce-Ball talk football, travel & language. They share their experiences of Macclesfield's FA Cup triumph and have their say on the Michael Carrick & Liam Rosenior appointments. John is getting ready for his trip to the Arctic. There's Clash of the Commentators controversy, more unintended pub names, and which commentary phrases will end up in our Great Glossary? Suggestions welcome on WhatsApp voicenotes to 08000 289 369 & emails to TCV@bbc.co.uk01:40 Macclesfield sprinkle the magic 09:40 Thoughts on Michael Carrick & Liam Rosenior 15:15 5 Live commentaries this weekend 18:05 John prepares for the Arctic! 21:40 Unintended pub names & railway stations 27:25 Clash of the Commentators 35:10 Great Glossary of Football Commentary 42:00 John's FA Cup error!5 Live / BBC Sounds commentaries: Sat 1500 Tottenham v West Ham, Sat 1500 Chelsea v Brentford on Sports Extra, Sat 1730 Nottingham Forest v Arsenal, Sun 1400 Wolves v Newcastle, Sun 1630 Aston Villa v Everton, Tue 1745 Bodø/Glimt v Man City, Tue 2000 Tottenham v Borussia Dortmund, Wed 2000 Newcastle v PSV, Wed 2000 Marseille v Liverpool on Sports Extra.Great Glossary of Football Commentary: DIVISION ONE Back to square one, Bosman, Cruyff Turn, Cultured/educated left foot, Dead-ball specialist, Draught excluder, Elastico/flip-flap Fox in the box, Giving the goalkeeper the eyes, Head tennis, Hibs it, In a good moment, In behind, Magic of the FA Cup, The Maradona, Off their line, Olimpico, Onion bag, Panenka, Park the bus, Perfect hat-trick, Rabona, Roy of the Rovers stuff, Schmeichel-style, Scorpion kick, Spursy, Tiki-taka, Trivela, Where the kookaburra sleeps, Where the owl sleeps, Where the spiders sleep.DIVISION TWO Back on the grass, Ball stays hit, Beaten all ends up, Blaze over the bar, Business end, Came down with snow on it, Catching practice, Camped in the opposition half, Cauldron atmosphere Coat is on a shoogly peg, Come back to haunt them, Corridor of uncertainty, Couldn't sort their feet out, Easy tap-in, Daisy-cutter, First cab off the rank, Giant-killing, Good leave, Half-turn, Has that in his locker, High wide and not very handsome, Hospital pass, Howler, In their pocket, Johnny on the spot, Leading the line, Nice headache to have, Nutmeg, One for the cameras, One for the purists, Played us off the park, Points to the spot, Prawn sandwich brigade, Purple patch, Put their laces through it, Reaches for their pocket, Rolls Royce, Root and branch review, Row Z, Screamer, Seats on the plane, Show across the bows, Slide-rule pass, Steal a march, Straight in the bread basket, Stramash, Taking one for the team, Telegraphed that pass, That's great… (football), Thunderous strike, Turns on a sixpence, Walk it in, We've got a cup tie on our hands.UNSORTED 2-0 is a dangerous score, After you Claude, All-Premier League affair, Aplomb, Bag/box of tricks, Brace, Brandished, Bread and butter, Breaking the deadlock, Bundled over the line, Champions elect / champions apparent, Clinical finish, Commentator's curse, Coupon buster, Denied by the woodwork, Draught excluder, Elimination line, Fellow countryman, Foot race, Formerly of this parish, Free hit, Goalkeepers' Union, Goalmouth scramble, Good touch for a big man, Honeymoon Period, In and around, In the shop window, Keeping ball under their spell, Keystone Cops defending, Languishing, Loitering with intent, Marching orders, Nestle in the bottom corner, Numbered derbies, Opposite number, PK for penalty-kick, Postage stamp, Put it in the mixer, Rasping shot, Red wine not white wine, Relegation six-pointer, Rooted at the bottom, Route One, Sending the goalkeeper the wrong way, Shooting boots, Sleeping giants, Slide rule pass, Small matter of, Spiders web, Stayed hit, Steepling, Stinging the palms, Stonewall penalty, Straight off the training ground, Taking one for the team, Team that likes to play football, Throw their cap on it, Thruppenny bit head / 50p head, Towering header, Two good feet, Turning into a basketball match, Turning into a cricket score, Usher/Shepherd the ball out of play, Walking a disciplinary tightrope, Wand of a left foot, Wrap foot around it, Your De Bruynes, your Gundogans etc.

Send us a textThis week on Neo News, we tackle the recent and controversial divergence between CDC and AAP guidelines regarding the birth dose of the Hepatitis B vaccine. With the CDC now recommending a deferred schedule for infants of Hepatitis B-negative mothers, we explore the clinical implications, the risks of vertical transmission, and the challenge of navigating discordant public health advice. We discuss how to handle shared decision-making in an era of waning vaccine confidence and why the "birth dose" remains a critical safety net in a community setting. Join us as we break down the data behind the headlines.----American Academy of Pediatrics. (2025, December 15). AAP: CDC decision on universal birth dose of hepatitis B vaccine irresponsible and purposely misleading. AAP News. https://publications.aap.org/aapnews/news/33980/AAP-CDC-decision-on-universal-birth-dose-of?searchresult=1?autologincheck=redirectedSupport the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

As you age, your thymus produces fewer newly formed cells responsible for responding to unfamiliar pathogens, reducing your immune system's adaptability. This shift, combined with persistent inflammation, defines the core features of immune aging Urolithin A, a postbiotic compound, stimulates mitochondrial renewal in aging immune cells. A recent study shows it can increase naïve-like T cells and strengthen immune surveillance in just four weeks of supplementation Clinical findings show that urolithin A boosts mitochondrial renewal pathways, increases markers linked to mitochondrial biogenesis, and improves immune cell metabolism Beyond immune health, studies reveal that urolithin A influences cancer pathways, enhances muscle strength and endurance, improves fatty liver markers, and reshapes metabolic signaling involved in obesity and insulin resistance Beyond using urolithin A, you can also support your mitochondria by lowering linoleic acid intake, eating the right carbohydrates, limiting environmental toxins, and supporting NAD⁺ production with niacinamide

In this episode of A Whole New Level, Dr. Eric Ravussin, PhD, explains the physiology of energy expenditure, metabolic adaptation, and why the body strongly defends its prior weight. Drawing on decades of research, including the Biggest Loser study, CALERIE, and work with metabolic chambers, Ravussin walks through what actually happens when we lose weight—and why willpower alone isn't enough.Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl In this episode, we cover:Why BMI is an incomplete measure of obesityThe difference between preclinical and clinical obesityHow energy expenditure really works (and why larger bodies burn more calories)What metabolic adaptation is—and why it persists long after weight lossWhy exercise alone rarely leads to sustained weight lossHow GLP-1 drugs intersect with appetite, metabolism, and muscle mass

Send us a textIn this episode of Journal Club, Ben and Daphna review a retrospective cohort study from the Journal of Perinatology examining the association between NICU capacity strain and neonatal outcomes. We discuss how high census and acuity on admission day correlate with increased mortality and morbidity when adjusted for hospital and patient factors. Join us as we explore why being "slammed with admissions" is more than just a badge of honor—it's a critical safety metric for our patients.----The association of NICU capacity strain with neonatal mortality and morbidity. Salazar EG, Passarella M, Formanowski B, Rogowski J, Edwards EM, Halpern SD, Phibbs C, Lorch SA.J Perinatol. 2025 Dec;45(12):1801-1808. doi: 10.1038/s41372-025-02449-0. Epub 2025 Oct 20.PMID: 41116036 Free PMC article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

While many perceive tinnitus as a problem solely with the ears, it is actually a neurological condition occurring in the auditory brain. The Auditory Brain Connection Because the brain possesses neuroplasticity—the ability to adapt and change—this "brain buzz" is not necessarily a permanent condition.In a deep dive into the subject, Dr. Ben Thompson, an audiologist and tinnitus expert, reveals that Tinnitus is not a disease itself, but rather a symptom of an underlying issue within the auditory system.  The Impact of Stress A healthy brain typically utilizes a filter mechanism to tune out background neural noise. However, during periods of significant stress, grief, or health anxiety, this filter weakens. This leads to a state of hypervigilance or a "startle response," causing the brain to perceive tinnitus sounds as much louder and more threatening than they truly are. Clinical Pathways to Recovery Recovery begins with sound therapy to avoid total silence, utilizing soft white noise to create a soothing environment, and maintaining proper sleep hygiene to regulate the nervous system.  For persistent cases, specialized interventions such as Tinnitus Retraining Therapy (TRT) and bimodal stimulation can help the brain habituate to the noise. The outlook is highly positive: with a structured protocol, 80% of patients experience a significant reduction in symptoms within six months. In this podcast you will learn: Why tinnitus is a neurological "brain buzz" rather than a disease. The way high stress and hypervigilance weaken the brain's internal filters. Immediate strategies for relief, including sound therapy and sleep hygiene. Clinical options like Tinnitus Retraining Therapy (TRT) and AI-driven hearing aids. How to move the body out of "fight-or-flight" to achieve long-term relief.   EPISODE RESOURCES: Youtube Facebook Instagram

Leading neurorehabilitation expert Julie Hershberg, PT, DPT, NCS, joins host J.J. Mowder-Tinney, PT, PhD, to dismantle the persistent myths and "weird" clinician behaviors that often hinder the treatment of functional neurological disorder (FND). Together, they bridge the gap between outdated assumptions and current neuroscience, exploring the predictive brain model and the high prevalence of comorbid conditions. You will learn why practitioners should shift from a diagnosis of exclusion to a positive clinical framework that prioritizes building trust and addressing underlying sensory processing difficulties. You will also gain actionable strategies to treat FND with the same clinical rigor and confidence as any other neurologic condition, ensuring your patients feel truly seen and supported.Learning ObjectivesAnalyze the evidence around functional neurological disorder (FND), including common myths, neurobiological mechanisms, and diagnostic clarityApply evidence-based, practical strategies to actionably address assessment and treatment planning for individuals with FND, including sensory, autonomic, and psychosocial factorsSolve patient case scenarios involving FND by using whole-person, trust-building approaches to guide interdisciplinary treatment and improve functional outcomesTimestamps(00:00:00) Welcome(00:00:05) Introduction and clinical training gaps(00:01:30) Guest background and professional evolution(00:03:37) Overcoming the stigma of "weird" therapy(00:08:30) Debunking common FND myths(00:10:10) Clinical diagnosis and neurological evidence(00:13:27) Reviewing current treatment research(00:16:30) Screening for comorbid conditions(00:18:10) Autonomic nervous system considerations(00:20:09) Integrating sensory and lifestyle factors(00:21:45) Patient triage and readiness for change(00:26:58) Acceptance of the brain-based model(00:29:04) Assessment priorities and heavy hitters(00:32:37) Practical sensory and autonomic interventions(00:35:45) Establishing radical trust with patients(00:37:46) Family education and environmental influence(00:39:55) Promoting patient advocacy and autonomy(00:46:10) Top three actionable takeaways(00:47:04) Case studies in holistic recovery(00:53:15) Creative adaptations in functional therapyNeuro Navigators is brought to you by Medbridge. If you'd like to earn continuing education credit for listening to this episode and access bonus takeaway handouts, log in to your Medbridge account and navigate to the course where you'll find accreditation details. If applicable, complete the post-course assessment and survey to be eligible for credit. The takeaway handout on Medbridge gives you the key points mentioned in this episode, along with additional resources you can implement into your practice right away.To hear more episodes of Neuro Naviagators, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.medbridge.com/neuro-navigators⁠⁠⁠⁠⁠⁠⁠⁠⁠If you'd like to subscribe to Medbridge, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.medbridge.com/pricing/⁠⁠⁠⁠⁠⁠⁠⁠⁠IG: ⁠⁠⁠⁠⁠⁠https://www.instagram.com/medbridgeteam/

In this solo episode, I am opening up about a big life change. I recently resigned from my clinical job. On paper it may sound simple, but the story under it holds a lot of layers, emotion, and growth. I talk about what led to my decision, what it brought up from my childhood, and how this shift is changing the way I raise my kids. If you grew up chasing safety, grades, or approval, parts of this will feel familiar. I get into: Why leaving a “stable” job can feel scary even when it is the right move Growing up with fear of failure and how that shaped my choices How the healthcare system wore me down over time The grief that comes with leaving patients, residents, and a place that shaped me Panic, burnout, and the signs your body gives you before your mind catches up How I want my kids to think about failure, risk, and self trust Why security matters and why quitting is not always simple or possible What it means to choose alignment even when fear is in the room Check out more on Poppins as I step into a new role there  00:00 – What Bravery Really Means 01:06 – Welcome and Finding Joy Returns 02:35 – Growing Up With Fear of Failure 03:48 – Why Medicine Felt Safe 04:25 – Burnout and Losing Alignment 04:46 – Building PedsDocTalk 05:31 – Signs It Was Time to Leave 06:45 – Choosing Risk and Entrepreneurship 07:46 – Grief, Loyalty, and Letting Go 09:09 – When the System Moves On Without You 09:53 – Breaking Generational Patterns 10:15 – What I Want My Kids to Learn 11:44 – Choosing Yourself Despite Uncertainty 12:45 – Questions to Find Your Own Alignment 13:30 – Closing and What's Next Our podcasts are also now on YouTube. If you prefer a video podcast with closed captioning, check us out there and ⁠subscribe to PedsDocTalk⁠. Get trusted pediatric advice, relatable parenting insights, and evidence-based tips delivered straight to your inbox—join thousands of parents who rely on the PDT newsletter to stay informed, supported, and confident. ⁠⁠⁠⁠Join the newsletter⁠⁠⁠⁠! And don't forget to follow ⁠⁠⁠⁠@pedsdoctalkpodcast⁠⁠⁠⁠ on Instagram—our new space just for parents looking for real talk and real support. We love the sponsors that make this show possible! You can always find all the special deals and codes for all our current sponsors on the ⁠PedsDocTalk Podcast Sponsorships⁠ page of the website.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Send us a textIn this episode of The Incubator Podcast, Ben and Daphna review a pivotal population-based study from Norway examining a new approach to Early-Onset Sepsis (EOS). The hosts discuss whether serial physical examinations can safely replace routine antibiotic prophylaxis in at-risk term and late-preterm infants. With antibiotic exposure often far exceeding sepsis incidence, this study offers compelling data for a "less is more" strategy. Tune in as Ben and Daphna explore the safety, efficacy, and bedside implications of substituting automatic treatment with structured clinical monitoring—and what this means for reducing unnecessary interventions in the NICU.----Serial physical examination to reduce unnecessary antibiotic exposure in newborn infants: a population-based study. Vatne A, Eriksen BHH, Bergqvist F, Fagerli I, Guthe HJT, Iversen KV, Ud Din FS, van der Weijde J, Kvaløy JT, Rettedal S.Arch Dis Child Fetal Neonatal Ed. 2025 Nov 19:fetalneonatal-2025-329639. doi: 10.1136/archdischild-2025-329639. Online ahead of print.PMID: 41260908Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Point-of-care engagement only works when technology serves real clinical workflows instead of forcing new ones. In this episode, Angelo Campano, CEO of Flora Health, discusses how his company bridges pharmaceutical manufacturers, health systems, and digital platforms to deliver relevant content to physicians at the exact moment of care. He explains how Flora helps brands show up inside EHR workflows without disrupting clinicians, why partnerships with health systems and technology vendors matter more than reinventing distribution, and how education closes the language gap between pharma and health IT. Angelo also shares the origin story behind Flora, his contrarian bet on market access over AI hype, and how automating prior authorization and patient assistance can dramatically improve access to therapy, especially for underserved populations. Drawing from his experience as an ultramarathon runner, he explains how “thinking in chapters” applies to building companies, measuring impact, and sustaining long-term innovation in healthcare. Tune in and learn how point-of-care strategy, market access, and disciplined execution can reshape patient access and outcomes! Resources Connect with and follow Angelo Campano on LinkedIn. Follow Flora Health on LinkedIn and visit their website!

As we kick off the new year, all four hosts are back for a discussion that every nurse anesthesia program will face at some point. We're sitting down together for a candid, experience-driven conversation about what accreditation really looks like from the inside, whether you're a program director, faculty member, or educator preparing for your first review. Drawing from multiple accreditation cycles, on-site visits, and self-study efforts, the panel discusses what works, what surprises programs, and why accreditation should be viewed as a measure of compliance, not a judgment of educational quality. We understand how overwhelming the process can feel at times, but getting guidance and resources from peers can help alleviate some of the pressure. Here's some of what you'll hear in this episode:

She was convinced it was her thyroid. After years of panic attacks, chronic anxiety, and a body that felt like it was "fighting something," she came to Ronda certain the answer was in her thyroid labs. It wasn't. In this Clinical Thinking case study, Ronda traces the real root cause back to compromised digestion and a nervous system running on stress hormones. This 28-year-old executive assistant had all the classic signs practitioners often miss: fasting glucose of 71 (a red flag for metabolic instability), light-colored stools, fatty food intolerance, and that telltale mid-back pain at the bra line. She'd been on Armour thyroid since age 13. She'd survived food poisoning in Costa Rica. And every single panic attack? Happened on a day she'd eaten chocolate. Ronda walks through how she connected the dots, why she started with upper digestion instead of adaptogens, how low glucose and low A1C reveal a system propped up by cortisol and adrenaline, and why the "obvious" first answer is almost never the right one. You'll also hear a practical tip for managing anxious patients: using AI to create organized visit recaps that satisfy their need for structure and reduce the between-appointment panic spirals. If you want to develop this kind of clinical thinking in your own practice, download Ronda's free guide: The 6 Principles of Clinical Thinking  

Dr. Refky Nicola speaks with Dr. Sven Haller about the current clinical use of AI-accelerated MRI, exploring how these techniques improve scan speed, patient comfort, workflow efficiency, and image quality. They also examine key challenges including hallucinations, validation gaps, economic considerations, and the need for clear standards to guide safe and effective adoption. The Current Status of AI-accelerated MRI Techniques in Clinical Use. Haller et al. Radiology 2025; 317(2):e24381

In this episode of Talk Nerdy, Cara is joined by licensed clinical psychologist, author, speaker, and educator, Dr. Jonathan Mathias Lassiter. They discuss his new book, How I Know White People are Crazy and Other Stories: Notes from a Frustrated Black Psychologist. Follow Jonathan: @lassiterhealth